Two Cases of Anti-PD1 Antibody Associated Neurological Immune-Related Adverse Effects

被引：0

作者：

Vitek, Grace ^{[1
]}

Hansra, Harjot ^{[2
]}

机构：

[1] Creighton Univ, Sch Med, Omaha, NE USA

[2] Dignity Hlth, Barrow Neurol Inst, San Francisco, CA USA

来源：

NEUROLOGY | 2023年 / 100卷 / 17期

关键词：

D O I：

10.1212/WNL.0000000000203811

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P5-4.001

引用

页数：3

共 50 条

[1] Experience of immune-related adverse events associated with anti-CTLA-4 and anti-PD1 checkpoint inhibitors in a single center
Rapoport, B. L.
Smit, T.
Van Eeden, R. I.
ANNALS OF ONCOLOGY, 2017, 28
[2] Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells
Gazzano, Marianne
Parizot, Christophe
Psimaras, Dimitri
Vozy, Aurore
Baron, Marine
Abbar, Baptiste
Fallet, Vincent
Litvinova, Elena
Canellas, Anthony
Birzu, Cristina
Pourcher, Valerie
Touat, Mehdi
Weiss, Nicolas
Demeret, Sophie
Roos-Weil, Damien
Spano, Jean-Philippe
Lebbe, Celeste
Salem, Joe-Elie
Cadranel, Jacques
Hervier, Baptiste
Gorochov, Guy
Guihot, Amelie
FRONTIERS IN IMMUNOLOGY, 2022, 13
[3] Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients
Cortellini, Alessio
Chiari, Rita
Ricciuti, Biagio
Metro, Giulio
Perrone, Fabiana
Tiseo, Marcello
Bersanelli, Melissa
Bordi, Paola
Santini, Daniele
Giusti, Raffaele
Grassadonia, Antonino
Di Marino, Pietro
Tinari, Nicola
De Tursi, Michele
Zoratto, Federica
Veltri, Enzo
Malorgio, Francesco
Garufi, Carlo
Russano, Marco
Anesi, Cecilia
Zeppola, Tea
Filetti, Marco
Marchetti, Paolo
Berardi, Rossana
Rinaldi, Silvia
Tudini, Marianna
Silva, Rosa Rita
Pireddu, Annagrazia
Atzori, Francesco
Iacono, Daniela
Migliorino, Maria Rita
Porzio, Gampiero
Cannita, Katia
Ficorella, Corrado
Buti, Sebastiano
CLINICAL LUNG CANCER, 2019, 20 (04) : 237 - +
[4] Immune-related bone marrow failure following anti-PD1 therapy
Michot, Jean-Marie
Vargaftig, Jacques
Leduc, Charlotte
Quere, Gilles
Burroni, Barbara
Lazarovici, Julien
Champiat, Stephane
Ribrag, Vincent
Lambotte, Olivier
EUROPEAN JOURNAL OF CANCER, 2017, 80 : 1 - 4
[5] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
Yeonghee Eun
In Young Kim
Jong-Mu Sun
Jeeyun Lee
Hoon-Suk Cha
Eun-Mi Koh
Hyungjin Kim
Jaejoon Lee
Scientific Reports, 9
[6] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
Eun, Yeonghee
Kim, In Young
Sun, Jong-Mu
Lee, Jeeyun
Cha, Hoon-Suk
Koh, Eun-Mi
Kim, Hyungjin
Lee, Jaejoon
SCIENTIFIC REPORTS, 2019, 9 (1)
[7] Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma
Alice Indini
Lorenza Di Guardo
Carolina Cimminiello
Michele Prisciandaro
Giovanni Randon
Filippo De Braud
Michele Del Vecchio
Journal of Cancer Research and Clinical Oncology, 2019, 145 : 511 - 521
[8] Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma
Indini, Alice
Di Guardo, Lorenza
Cimminiello, Carolina
Prisciandaro, Michele
Randon, Giovanni
De Braud, Filippo
Del Vecchio, Michele
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (02) : 511 - 521
[9] Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series
Smith, Jessica Louise
Menzies, Alexander M.
Cohen, Justine, V
Mut-Lloret, Margarida
Ozgun, Alpaslan
Spain, Lavinia
Park, John
Quach, Henry T.
Pallan, Lalit
McQuade, Jennifer
Feng, Sophie
Sandhu, Shahneen
Atkinson, Victoria
Tsai, Katy
Long, Georgina, V
Larkin, James
Eroglu, Zeynep
Johnson, Douglas B.
Sullivan, Ryan
Herkes, Geoffrey K.
Henderson, Andrew
Carlino, Matteo S.
MELANOMA RESEARCH, 2022, 32 (06) : 451 - 459
[10] Anti-PD-1 antibodies: immune-related adverse events and efficacy
Reactions Weekly, 2019, 1739 (1) : 6 - 6

← 1 2 3 4 5 →